Top 10 Companies in the Mesalamine API Industry (2025): Market Leaders Revolutionizing IBD Therapeutics
The Global Mesalamine API Market was valued at USD 180 million in 2023 and is projected to reach USD 249.62 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period (2024-2032). This expansion is fueled by rising IBD prevalence, improved treatment protocols, and increasing demand for high-purity active […]